HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ezlopitant

structure in first source
Also Known As:
(2S,3S,4S)-2-diphenylmethyl-3-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane; 1-Azabicyclo(2.2.2)octan-3-amine, 2-(diphenylmethyl)-N- ((2-methoxy-5-(1-methylethyl)phenyl)methyl)-, (2S-cis)-; 2-diphenylmethyl-3-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane; (2S,3S)-2-(Diphenylmethyl)-3-((5-isopropyl-2-methoxy- benzyl)amino)quinuclidine
Networked: 4 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shimada, Kaoru: 1 article (11/2002)
2. Ueda, Satoko: 1 article (11/2002)
3. Suga, Osamu: 1 article (11/2002)
4. Kanai, Yoshihito: 1 article (11/2002)
5. Nagahisa, Atsushi: 1 article (11/2002)
6. Fujiwara, Yoshiko: 1 article (11/2002)
7. Tsuchiya, Megumi: 1 article (11/2002)
8. Mizutani, Mayumi: 1 article (11/2002)
9. Watson, John W: 1 article (11/2002)
10. Callahan, Michael J: 1 article (07/2002)

Related Diseases

1. Vomiting
2. Pain (Aches)
3. Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
4. Dehydration (Water Stress)

Related Drugs and Biologics

1. Cisplatin (Platino)
2. Benzyl Alcohol (Benzenemethanol)
3. Cytochrome P-450 CYP2D6 (CYP2D6)
4. Tachykinins
5. Deuterium

Related Therapies and Procedures

1. Subcutaneous Injections
2. Intraperitoneal Injections